Idhifa - NDC Alphabetical Drug Index

List of NDC products with proprietary name idhifa. This medication is used to treat a certain type of blood cell cancer (acute myeloid leukemia-AML). Enasidenib works by helping your bone marrow grow normal blood cells so you will need fewer blood transfusions.

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Labeler Name Product Type
59572-705Idhifa Enasidenib MesylateTablet, Film CoatedOralCelgene CorporationHuman Prescription Drug
59572-710Idhifa Enasidenib MesylateTablet, Film CoatedOralCelgene CorporationHuman Prescription Drug